GGrantIndex
← Leaderboards

Robert S Krouse

University Of Arizona

$7,183,248
Attributed
$8,216,169
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $738.4K · FY200523
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$7,066,562 · 4
AHRQ$1,149,607 · 1

By mechanism

R01$7,901,702 · 3
R21$294,467 · 1
R13$20,000 · 1

Top collaborators

Most similar at University Of Arizona

Same institution · by research overlap

Others in their field

Top investigators on “Ostomy

Research focus

OstomyChronicCaringProgramsFaceCancer SurvivorMalignant NeoplasmsEvidence BaseHealth Related Quality Of LifeMedicalStomasComorbidityOperative Surgical ProceduresSurvivorsParticipantAffectBehavioralCommunitiesRectal CancerBaseResponseDisabilityAreaCommunication

Grant awards (25)

Ostomy Telehealth Self-management Training for Cancer Survivors$618,471
R01 · FY2023 · CA · contact PI
Ostomy Telehealth Self-management Training for Cancer Survivors$620,800
R01 · FY2022 · CA · contact PI
Ostomy Telehealth Self-management Training for Cancer Survivors$638,453
R01 · FY2021 · CA · contact PI
Ostomy Telehealth Self-management Training for Cancer Survivors$99,939
R01 · FY2021 · CA · contact PI
Ostomy Telehealth Self-management Training for Cancer Survivors$646,527
R01 · FY2020 · CA · contact PI
Ostomy Telehealth Self-management Training for Cancer Survivors$704,683
R01 · FY2019 · CA · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$250,000
R01 · FY2017 · HS · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$229,427
R01 · FY2016 · HS · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$150,176
R01 · FY2015 · HS · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$73,171
R01 · FY2015 · HS · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$213,585
R01 · FY2014 · HS · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$378,060
R01 · FY2013 · CA · contact PI
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction$233,248
R01 · FY2013 · HS · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$406,081
R01 · FY2012 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$419,247
R01 · FY2011 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$418,046
R01 · FY2010 · CA · contact PI
HRQOL-enhancing ostomy self-management intervention for CRC survivors$128,147
R21 · FY2010 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$444,408
R01 · FY2009 · CA · contact PI
HRQOL-enhancing ostomy self-management intervention for CRC survivors$166,320
R21 · FY2009 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$376,997
R01 · FY2006 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$82,588
R01 · FY2006 · CA · contact PI
HR-QOL in Colorectal Cancer Survivors with Stomas$404,057
R01 · FY2005 · CA
HR-QOL in Colorectal Cancer Survivors with Stomas$80,332
R01 · FY2005 · CA
HR-QOL in Colorectal Cancer Survivors with Stomas$413,406
R01 · FY2004 · CA
International Conference on Malignant Bowel Obstruction$20,000
R13 · FY2004 · CA